Newsletter | November 26, 2024

11.26.24 -- Maintaining Harmony With Your CDMO Using 'The Middle Way'

SPONSOR

Webinar: Early Preclinical Development of mRNA/LNP projects - Setting Up Your Project for a Successful Transition to cGMP Manufacturing

Join us on December 2nd to explore mRNA construct development at Lonza, focusing on cGMP manufacturing, analytical advancements, and testing methods. Gain insights into the transition from research to manufacturing and the technologies shaping mRNA development for future projects. Click here to learn more.

FOCUS ON OUTSOURCING

Maintaining Harmony With Your CDMO Using 'The Middle Way'

Sponsor and CDMO relationships are fertile ground for conflict. A measured approach can mitigate disruptions with troublesome contractors and high performers alike.

Setting The Standard For Plasmid DNA Production

Discover how Boehringer Ingelheim’s expertise in plasmid DNA manufacturing can propel your innovative therapies forward and transform patient care.

Bacteria Media Optimization Using In Silico Strategies

Determining ideal media composition for a bacteria is critical because it fosters a satisfactory grow rate, allowing the bacteria to reach the required growth yield.

The Right Partnerships Are Key To Streamlined Drug Development

Explore how to select the right CDMO partner for your pharmaceutical project to navigate the evolving drug development landscape and ensure successful outcomes.

Keys To A Successful cGMP Manufacturing Operation Delivering CGTs

Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of every day, manufacturing operational excellence.

Realizing The Potential Of Intensified Scalable Adherent Cell Culture

Review the importance of alternative approaches to viral vector production and the benefits of intensified adherent cell culture for improving efficiency, reducing costs, and accelerating development.

Why A CDMO In Poland Might Be Your Secret Weapon

The current geopolitical climate is leading drug developers to consider global manufacturing partnerships strategically. Identify a CDMO partner that will help protect your IP, save money, and mitigate risk.

A CDMO's Checklist For Prospective Clients: Part 3

In the last entry of our client checklist series, we delve into crucial aspects such as project management, decision-making, MSA negotiations, and building trust in CDMO-client partnerships.

Collaboration For Clinical To Commercial Manufacturing Success

Begin your ADC manufacturing journey by finding a partner who can provide support through every phase of the conjugate life cycle, including process optimization, scale-up, and validation.

3 Key Considerations When Choosing A Partner For Your Tech Transfer

One way to streamline tech transfer is to partner with a CMO demonstrating a proven track record across the entire drug development and manufacturing continuum.

Developing Robust mRNA Processes In A cGMP Environment

Explore current and emerging technologies to optimize mRNA manufacturing, especially when considering commercial production and the validation of processes in a cGMP environment.

A Closer Look At The Fast-Tracked CLD Platform Of The Future

Learn how adopting an innovative cell line development platform can help companies streamline their development and production processes, reduce timelines, and achieve higher production levels.

3 Keys To Success When Planning With Your CMO Partner

Once you've identified a CMO partner, how do you ensure success? The secret: planning as early as possible – while your product is still in preclinical or clinical development.

Innovations In ADC Technologies

Examine the drivers behind the recent successes in the clinic, current challenges with development and manufacturing, and what the future might hold for the ADC industry.

OUTSOURCING SOLUTIONS

Innovative Manufacturing Dedicated To The Cell And Gene Therapy Industry - Aldevron

Helping Cell Therapy Innovators Bring Treatments To Market - Kincell Bio

A Complete Set Of Rapid Methods For Adventitious Agent Detection - MilliporeSigma

Customized CMC Solutions - Samsung Biologics

mAb/Recombinant Protein Lot Release Package - WuXi Advanced Therapies

Exploring Oligos And Peptides For Pharma Manufacturing: Features And Benefits Of AJIPHASE Technologies - Ajinomoto Bio-Pharma Services

Choosing A CDMO With Capacity Designed For You - INCOG BioPharma Services

Allogeneic And Autologous Cell Therapy CDMO Services - FUJIFILM Diosynth Biotechnologies

The Andelyn Difference - Andelyn Biosciences

TAAV And Viralgen Together As Your rAAV Manufacturing Solution - Viralgen

Connect With Bioprocess Online: